|
Ostroumova O.D., Telkova S.S., Dubinina A.V., Klepikova M.V., Kochetkov A.I.
Non-alcoholic fatty liver disease as a trigger of polymorbidity. Is there a way out of the impasse?
|
№4 / 2024
|
|
O.A. Polyakova, Yu.M. Tkachenko, O.D. Ostroumova
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid
|
№1-2 / 2023
|
|
O.A. Polyakova, L.D. Kozgunova, O.D. Ostroumova
Metabolically associated fatty liver disease: the role of ademetionine
|
№1-2 / 2023
|
|
N.I. Volkova, S.O. Panenko, A.O. Golubeva
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
|
№12 / 2021
|
|
L.V. Tarasova (1, 2, 3), Yu.V. Tsyganova (3), E.I. Busalaeva (3, 4), O.L. Aryamkina (1)
Analysis of the methods of treatment of non-alcoholic fatty liver disease: focus on innovations
|
№2 / 2019
|
|
S.A. Bulgakov
ESSENTIAL PHOSPHOLIPIDS IN THE TREATMENT OF HEPATIC DISORDERS
|
№s3 / 2018
|
|
V.G. Radchenko, P.V. Seliverstov, V.F. Ivanova, S.I. Sitkin
ALGORITHM OF TREATMENT OF NON-ALCOHOLIC FATTY OF LIVER DISEASE AND THE ROLE OF MITOCHONDRIAL DYSFUNCTION IN ITS DEVELOPMENT
|
№6 / 2017
|
|
A.F. Verbovoy, L.A. Sharonova, A.V. Pashentseva, I.A. Tsanava
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
|
№5 / 2017
|
|
A.N. Kazyulin
POTENTIALS FOR THE EARLY PROPHYLAXIS OF PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN THE PRACTICE OF CLINICISTS
|
№2 / 2017
|
|
E.N. Shirokova
NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK (LITERATURE REVIEW)
|
№2 / 2017
|
|
E.A. Mironova (1), O.E. Berezutskaya (2), N.L. Golovkina (2)
NONALCOHOLIC FATTY LIVER DISEASE: MODERN OPPORTUNITIES OF THERAPY
|
№15 / 2016
|
|
L.A. Zvenigorodskaya, M.V. Shinkin, T.V. Nilova, A.V. Petrakov, A.E. Lychkova
LIPID PEROXIDATION AND ACTIVITY OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN THE SERUM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
|
№15 / 2016
|
Русский
